TMCnet News
Glytec Announces Late Breaking Abstracts Accepted for Poster Presentations at American Association of Clinical Endocrinologists 23rd Annual Scientific & Clinical CongressGREENVILLE, S.C. --(Business Wire)-- Glytec, LLC, a clinical information technology company dedicated to the mission of improving insulin management and glycemic control, announced today that several late breaking abstracts featuring the company's eGlycemic Management System™ have been accepted for poster presentations at the American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress, taking place from May 14 - May 18, 2014, in Las Vegas. The posters will be displayed from 9:30 a.m. to 1:00 p.m. on Saturday, May 17th in the General Poster Sessions in the exhibit hall. Presentations by the lead authors will occur from 9:45 a.m. to 11:00 a.m. on Saturday, May 17th. Late breaking abstracts allow for a later submission of new and cutting edge research. The abstracts will be published in an online supplement to the AACE annual meeting syllabus. Conducted by researchers from Duke University School of Nursing, Piedmont Healthcare, Jackson Madison County General Hospital, Sentara Health System and Eastern Virginia Medical School, the poster presentations will highlight research results evaluating Glytec's eGlycemic Management System in three leading acute care hospitals. Two of the poster presentations include:
The first poster listed above will be presented by Joseph Aloi, MD, Director, Strelitz Diabetes Center, Eastern Virginia Medical School. The second poster will be presented by Melanie Mabrey, DNP, RN, Assistant Professor, Duke University School of Nursing. "We are excited to be participating in this year's AACE meeting, which is one of the largest meetings in the U.S. for health care professionals to discuss and learn about the latest advances in endocrinology," said Bob Leonard, Chief Executive Officer of Glytec. As we proceed with the expansion of our comprehensive eGlycemic Management System and SubQ insulin dosing capabilities, we are pleased that we are able to showcase the value of our solutions to a wide audience of healthcare practitioners." About Glytec Founded in 2006, Glytec is a rapidly growing clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control. The eGlycemic Management System™ (eGMS™) enables hospitals and healthcare systems to significantly reduce the frequency, risks and costs of hyperglycemia and hypoglycemia and offer superior care to their diabetic and surgical patients. Glytec's solution has evolved dramatically over its eight year history; from the very first of its kind, computerized IV insulin dosing tool to the first and only comprehensive, integrated glycemic management and surveillance system. The eGMS includes the only suite of FDA-cleared, computerized, predictive dosing algorithms for IV, subcutaneous and pediatric dosing: Glucommander IV™ (FDA clearance 2006), Glucommander SubQ™ (FDA clearance 2010) and Glucommander Pediatrics™ (FDA clearance 2012). The unique breadth and depth of the Glucommander Suite™ allows hospitals to standardize its approach across all areas of the hospital. For more information, please visit www.glytecsystems.com. |
